Prof Jordi Giralt speaks to ecancer.tv about the results his recent trial into head and neck cancer. This trial showed that less than optimal quality radiotherapy led to a 20% drop in survival rates. This research has important implications including the need for quality control at the start of all future radiotherapy clinical trials. Prof Giralt concludes by discussing a trial demonstrating that hyperfractionation radiotherapy reduces toxicity and may increase local regional control.